BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.23, Iss.1, 2014-01, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics

By Borowicz K.K. Gasior M. Kleinrok Z. Czuczwar S.J.

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 319-326

Elsevier

Access to resources Recommend Favorite

Influence of agents affecting voltage-dependent calcium channels and dantrolene on the anticonvulsant action of the AMPA/kainate receptor antagonist LY 300164 in mice

By Swiader M. Borowicz K.K. Porebiak J. Kleinrok Z. Czuczwar S.J.

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 311-319

Elsevier

Access to resources Recommend Favorite

Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam

By Borowicz K.K. Luszczki J. Szadkowski M. Kleinrok Z.x. Czuczwar S.x.J.

European Journal of Pharmacology, Vol. 380, Iss. 2, 1999-09 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite

Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders

By Lees G.J.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 33-78

Adis International

Access to resources Recommend Favorite

LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs

By Czuczwar S.J. Swiader M. Kuzniar H. Gasior M. Kleinrok Z.

European Journal of Pharmacology, Vol. 359, Iss. 2, 1998-10 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite